TrialX
Image

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

Recruiting
18 years and older
All
Phase 3

Overview

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Eligibility

Inclusion Criteria:

  1. Male or female 18 years of age or older.
  2. Moderate to severe LCL at maximum smile as assessed by the Investigator.
  3. Moderate to severe LCL at maximum smile as assessed by the subject.
  4. Moderate to severe GL at maximum frown as assessed by the Investigator.
  5. Moderate to severe GL at maximum frown as assessed by the subject

Exclusion Criteria:

  1. Previous use of any Botulinum toxin in facial areas within 9 months prior to study treatment.
  2. Female who is pregnant, breast feeding, or intends to conceive a child during the study.
  3. Known allergy or hypersensitivity to any component of the investigational product (QM1114-DP).

Study details
    Lateral Canthal Lines
    Glabellar Frown Lines (GL)

NCT04247074

Q-Med AB

16 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.